Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis. Keystone, E. C., Taylor, P. C., Genovese, M. C., Schlichting, D. E., De La Torre, I., Beattie, S. D., Rooney, T. WILEY-BLACKWELL. 2014: S1232
View details for Web of Science ID 000344384906057